| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,099,100 | 856,000 | 922,500 | 1,870,600 | | Cost of Revenue | 752,900 | 685,400 | 692,900 | 993,500 | | | Gross Profit | 346,200 | 170,600 | 229,600 | 877,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,000 | 70,300 | 41,400 | 136,500 | | Non Recurring |
-
| 30,200 | (30,200) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 574,100 | 70,100 | 218,400 | 740,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 112,100 | 151,800 | 2,000 | 312,600 | | Earnings Before Interest And Taxes | 358,400 | 283,800 | 220,400 | 860,200 | | Interest Expense | 31,100 | 24,500 | 25,200 | 6,700 | | Income Before Tax | 327,300 | 259,300 | 195,200 | 853,500 | | Income Tax Expense | 71,600 | 79,100 | (113,100) | 165,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 249,900 | 186,000 | 308,300 | 688,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 249,900 | 186,000 | 308,300 | 688,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $249,900 | $186,000 | $308,300 | $688,000 |
|
1.52% Nasdaq 0.00%
Income Statement
